Table 1.
Intervention group | Control group | |
---|---|---|
n = 30 | n = 38 | |
Age, mean (SD) years | 13.4 (3.1) | 13.1 (3.1) |
Gender, male n (%) male | 16 (53%) | 21 (55%) |
Height, mean (SD) cm | 158.9 (16.5) | 154.5 (17.2) |
Weight, mean (SD) kg | 51.6(16.0) | 49.2 (16.9) |
Cancer type, n (%) | ||
ALL | 8 (27%) | 12 (32%) |
AML, HL, non-HL, CML, Burkitt | 12 (40%) | 13 (34%) |
CNS/brain tumor | 1 (3%) | 6 (16%) |
Solid tumor | 9 (30%) | 7 (18%) |
During treatment, n (%) | 9 (30%) | 12 (32%) |
Lower body amputations | 2 (3%) | 2 (3%) |
Upper body amputations | 2 (3%) | 1 (1%) |
Abbreviations: SD standard deviation, N number, ALL acute lymphoblastic leukemia, AML acute myeloid leukemia, HL Hodgkin lymphoma, non-H non-Hodgkin lymphoma, CML chronic myeloid leukemia, CNS central nervous system
*No significant differences at baseline between the two groups